Your browser doesn't support javascript.
loading
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
Sidiqi, M Hasib; Al Saleh, Abdullah S; Kumar, Shaji K; Leung, Nelson; Jevremovic, Dragan; Muchtar, Eli; Gonsalves, Wilson I; Kourelis, Taxiarchis V; Warsame, Rahma; Buadi, Francis K; Lacy, Martha Q; Kyle, Robert A; Go, Ronald; Hobbs, Miriam; Dispenzieri, Angela; Dingli, David; Hayman, Suzanne R; Gertz, Morie A; Rajkumar, S Vincent; Kapoor, Prashant.
Afiliación
  • Sidiqi MH; Haematology Department, Fiona Stanley Hospital, Perth, Western Australia, Australia.
  • Al Saleh AS; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Kumar SK; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Leung N; Division of Haematology and HSCT, Department of Oncology, King Abdul Aziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
  • Jevremovic D; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Muchtar E; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Gonsalves WI; Division of Nephrology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Kourelis TV; Division of Hematopathology, Mayo Clinic Rochester, Rochester, Minnesota, USA.
  • Warsame R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Buadi FK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Lacy MQ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Kyle RA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Go R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Hobbs M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Dingli D; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Hayman SR; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Gertz MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Kapoor P; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol ; 96(9): 1131-1136, 2021 09 01.
Article en En | MEDLINE | ID: mdl-34115387
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Compuestos Bicíclicos Heterocíclicos con Puentes / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Compuestos Bicíclicos Heterocíclicos con Puentes / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article